Constellation Healthcare Technologies' revenues increased by 78% to $57.0m in the six months to the end of June.
The group said the business continues to outperform with each one of its segments showing robust growth in revenue and earnings over the course of the year.
CHT anticipates that this will continue throughout the year.
CHT says the business is very strong and while maintaining organic growth, it can easily be scaled with new acquisitions which will further cement earnings for the coming years.
CHT's EBITDA increased by 121% to $21.1m and EBITDA margins have also increased by 7% to 37% based on the same period last year. Cash from operations increased by 160% to $10.9.0m.
Chief executive Paul Parmar said: "CHT has built a robust platform based on its efficient RCM processes and technologies. Coupled with a tried, tested and matured methodology of integrating and transitioning new clients and new business onto this highly scalable platform, this platform and experience allows CHT to rapid growth.
"We are now starting to see the benefits of this investment as evidenced by the 78% increase in revenues with 22% of the revenue coming from organic growth and very strong cash generated from operations as evidenced by a 160% increase as compared to the same period last year.
"We strongly believe that our platform and our integration methodology along with the experience we have gained, uniquely places us to grow the business rapidly through organic growth and M&A.
"At this point in time we feel very confident having delivered above expectations for the first half of 2016, that we will meet the markets guidance on revenue as well as profits for the full year 2016."